| Prostate Cancer - Prostate cancer urine test identifies men who can safely avoid immediate treatment |
|
|
|
|
| |
|
| |
The latest prostate cancer news from News Medical |
|
|
|
 | | |
 Understanding the current medical landscape of prostate cancer
In this interview, News-Medical talks to Dr. Simon Chowdhury, Consultant Medical Oncologist, and Laetitia Decroix Guilloux, Vice President, EMEA Commercial Strategy Lead at Janssen Oncology, to discuss the unmet needs in prostate cancer, scientific advancements, and Janssen’s heritage in the disease area.
| |
|
|
| | | | |  The risk of prostate cancer was 24% higher among 9/11 rescue and recovery workers after the attacks on the World Trade Center in 2001, with the highest risk among the earliest responders, finds research published online in the journal Occupational & Environmental Medicine. | | | | |  A new meta-analysis finds that a genetic biomarker test accurately predicts how men with high-risk prostate cancer will respond to treatment with radiation and hormone therapy. | | | | |  Nearly half of men initially managed with active surveillance for "low-risk" prostate cancer transition to definitive treatment – such as surgery or radiation therapy – within a few years after diagnosis. | | | | |  For men with "low-risk" prostate cancer initially managed with active surveillance, cancer-related factors such as tumor grade and size are key risk factors for conversion to active treatment, reports a study in The Journal of Urology®, an Official Journal of the American Urological Association. | | | | |  A team of Beaumont Health researchers from Radiology, Radiation Oncology and Urology studied the relationship between benign prostatic hyperplasia, or BPH, and prostate cancer in 405 men by quantitatively looking at different parts of prostate tissue on MRI. | | | | |  The relative cardiovascular safety of different types of androgen deprivation therapy (ADT) for prostate cancer remains unresolved after the PRONOUNCE trial was terminated early. The late breaking research is presented in a Hot Line session today at ESC Congress 2021. | |
|
|
|
|
|
|
|
